Insider Transactions in Q4 2021 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,101
+1.32%
|
-
|
|
Dec 29
2021
|
Taylor Sandison Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,600
+5.74%
|
-
|
|
Dec 29
2021
|
Brady Johnson Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
262
+0.51%
|
-
|
|
Dec 29
2021
|
Jeffrey Stein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.92%
|
-
|
|
Dec 29
2021
|
Paul Daruwala Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,900
+4.89%
|
-
|
|
Nov 12
2021
|
Preetam Shah Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$20,000
$1.54 P/Share
|
|
Nov 12
2021
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+9.69%
|
$50,000
$1.59 P/Share
|